On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies

The analysis of adverse events (AEs) is a key component in the assessment of a drug's safety profile. Inappropriate analysis methods may result in misleading conclusions about a therapy's safety and consequently its benefit‐risk ratio. The statistical analysis of AEs is complicated by the...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Pharm Stat
Main Authors: Unkel, Steffen, Amiri, Marjan, Benda, Norbert, Beyersmann, Jan, Knoerzer, Dietrich, Kupas, Katrin, Langer, Frank, Leverkus, Friedhelm, Loos, Anja, Ose, Claudia, Proctor, Tanja, Schmoor, Claudia, Schwenke, Carsten, Skipka, Guido, Unnebrink, Kristina, Voss, Florian, Friede, Tim
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2018
נושאים:
Main Papers
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587465/
https://ncbi.nlm.nih.gov/pubmed/30458579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1915
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים